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Figure S1: TLR7 stimulation decreases MDSC in 4T1 tumor-bearing mice. 
Flow cytometry analysis of MDSC subpopulations in tumor and spleen from 4T1 tumor-bearing 
mice injected with two cycles of two injections of 25 μg R848 at a 24-h interval (5 days between 
the two cycles). Mice were sacrificed 18h after the last injection. Dot plots from one 
representative mouse per group and means of 3 mice/group are shown. Error bars show SEM. 
*p<0.05. Student’s t-test.
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Figure S2: TLR7 stimulation prevents growth of CT26 tumors. 
CT26 tumor-bearing mice were treated repeatedly with two injections of 25 μg R848 or with PBS 
(black arrows). Mean ± SEM of tumor area measured for individual mice (n=5) are shown. Data 
are representative of 3 independent experiments. **p<0.01, ****p<0.0001. ANOVA with 
Bonferroni’s post-test.
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